Cattle: Diseases

(asked on 21st February 2025) - View Source

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, what progress his Department has made on the (a) development and (b) deployment of vaccines for bovine diseases in the last 12 months.


Answered by
Daniel Zeichner Portrait
Daniel Zeichner
Minister of State (Department for Environment, Food and Rural Affairs)
This question was answered on 2nd April 2025

Defra continues to invest in bovine disease research, and we continue to monitor the current situation and vaccine usage both in Europe and globally for both exotic and endemic diseases. Defra, in conjunction with the Veterinary Medicines Directorate (VMD), will continue to monitor the development and availability of vaccines for their utility in preventing and responding to disease outbreaks as they are put forward for market authorisation by vaccine manufacturers.

To support this work Defra has established cross-Government and industry taskforces focusing on avian influenza and bluetongue. The avian influenza vaccination taskforce published an initial statement on 7 March 2025 and will publish their report this summer. While the avian influenza vaccination taskforce focus is on poultry, they are also alert to the ongoing outbreak in cattle in the USA of influenza of avian origin.

The Government maintains a vaccine bank for foot and mouth disease and lumpy skin disease, exotic diseases affecting cattle. Defra has also engaged with manufacturers on supply of vaccines to the UK market for bluetongue virus serotype 3 (BTV-3) and epizootic haemorrhagic disease virus (EHDV). Following this engagement, and assessment of vaccines by the VMD, Defra’s Secretary of State permitted the use of three unauthorised BTV-3 vaccines for use in England since September 2024, giving keepers the choice to protect their animals.

A cattle vaccine for bovine TB is in development. The CattleBCG vaccine, when coupled with the new Detect Infected amongst Vaccinated Animals (DIVA) skin test, represents a significant advancement in bovine TB control for cattle herds. Field trials began in June 2021 and are on-going.

An injectable BCG vaccine for badgers has been licensed since 2010 and is proven to significantly reduce the risk of infection and spread of bovine TB within badger populations. The number of badgers vaccinated continues to rise in England, with preliminary figures suggesting around 4,000 were vaccinated in 2024. This is the highest number ever vaccinated in England in a single year, exceeding the record set in 2023. In August 2024, the government announced steps to continue increasing vaccination deployment and to analyse the effect of badger vaccination on the incidence of TB in cattle. This includes establishing a new Badger Vaccinator Field Force.

Reticulating Splines